tradmap

IQV IQVIA

$167.69 -1.74%

S&P 500 Companies

Held by SPYVOOIVV

Industrials · Services-Commercial Physical & Biological Research

IQVIA (IQV) is a industrials company in the Services-Commercial Physical & Biological Research industry, with a market capitalization of $28.0 billion. Shares last traded at $167.69, 32.1% below their 52-week high. Over the past year the stock is up 8.8%. IQV trades at a price-to-earnings ratio of 20.58, below the Services-Commercial Physical & Biological Research median of 24.86. Net profit margin is 8.3%, in line with the peer median of 8.4%. Revenue grew 5.9% year over year.

Market Cap
$28.0B
Shares Out
166.9M
EPS (TTM)
$10.81
P/E Ratio
15.51
P/S Ratio
1.72
P/B Ratio
4.50
Dividend / Share
Dividend Yield
52-Week High
$246.82
52-Week Low
$153.02
Volume
180,374
Avg Vol (3m)
113,749.635

Performance

1W
-7.39%
1M
-3.18%
3M
+0.76%
6M
-24.36%
YTD
-25.59%
1Y
+8.84%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
39.70
SMA (50)
$173.26
SMA (200)
$195.26
Price vs SMA50
-3.22%
Price vs SMA200
-14.12%
ATR (14)
$6.53

Financials

Revenue
$16.3B
Net Income
$1.4B
Gross Margin
Operating Margin
13.4%
Net Margin
8.3%
Return on Equity
21.9%
Return on Assets
4.6%
Current Ratio
0.75
Debt / Equity
2.25
Revenue Growth (YoY)
+5.9%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

PeriodEPS (diluted)Reported
Q1 2026 $1.61 2026-05-05
FY 2025 $7.84 2026-02-17
Q3 2025 $4.86 2025-10-28
Q2 2025 $2.94 2025-07-22
Q1 2026 $1.40 2026-05-05
FY 2025 $7.49 2026-02-17

Full earnings history →

Services-Commercial Physical & Biological Research peers

IQV vs 12 industry peers (Services-Commercial Physical & Biological Research), by market cap.

P/E vs peers
20.58 / 24.86 med
-17% discount
P/S vs peers
1.72 / 3.04 med
-44% discount
Net margin vs peers
8.3% / 8.4% med
below median
1–12 of 12
IQVIQVIA$28.0B20.581.728.3%-1.74%
INCYIncyte$19.6B15.263.8225.0%-0.73%
MEDPMedpace Holdings, Inc.$13.1B29.145.1917.8%+0.66%
CRLCharles River Laboratories$8.9B-61.772.22-3.6%+1.47%
ABSIAbsci Corp$1.2B-10.00+3.07%
NRCNrc Health$418M36.043.048.4%+4.57%
OABIOmniAb, Inc.$339M-5.24+15.27%
MXCTMAXCYTE, INC.$129M-2.88+5.73%
ONMDOneMedNet Corp$31M-10.93-5.21%
BIAFbioAffinity Technologies, Inc.$4M+0.63%
ISPCiSpecimen Inc.$4M-0.36+0.38%
ICLRIcon Plc2.8%+1.94%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.